Monoclonal Antibody Treatments
- All
- News
-
Medical Breakthrough: Study Finds New Treatment Effective For Rare Liver Disease
A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing cholangitis (PSC).
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
India To Get 20 More Doses Of Antibody From Australia To Treat Nipah
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, the Indian Council of Medical Research (ICMR) said on Friday.
-
India To Get These Antibodies From Australia For Nipah Treatment
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, ICMR DG Rajeev Bahl said on Friday.
-
Monoclonal Antibody, Only Treatment Against Nipah Infection, Reaches Kerala
The monoclonal antibody required to treat the Nipah virus infection has arrived in the state, Kerala said today.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
On Covid Antibody Therapy, Top Virologist: "Unethical, Unscientific"
Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
Monoclonal Antibody Treatment Combo Cuts Hospitalisation Among High-Risk Covid Patients: Study
A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
-
Medical Breakthrough: Study Finds New Treatment Effective For Rare Liver Disease
A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing cholangitis (PSC).
-
New Asthma Treatment Offers Hope With Reduced Steroid Dependence
Research indicates that severe asthma can be managed effectively through biologic therapies, eliminating the need for additional high-dose inhaled steroids with potential significant side effects.
-
India To Get 20 More Doses Of Antibody From Australia To Treat Nipah
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, the Indian Council of Medical Research (ICMR) said on Friday.
-
India To Get These Antibodies From Australia For Nipah Treatment
India will procure from Australia 20 more doses of monoclonal antibody for the treatment of Nipah virus infection, ICMR DG Rajeev Bahl said on Friday.
-
Monoclonal Antibody, Only Treatment Against Nipah Infection, Reaches Kerala
The monoclonal antibody required to treat the Nipah virus infection has arrived in the state, Kerala said today.
-
Patients With High Covid Risk Least Likely To Get Monoclonal Antibodies: Study
According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.
-
On Covid Antibody Therapy, Top Virologist: "Unethical, Unscientific"
Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
Monoclonal Antibody Treatment Combo Cuts Hospitalisation Among High-Risk Covid Patients: Study
A combination of 2 monoclonal antibody treatments keeps high-risk Covid patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet's EClinicalMedicine journal.
-
Delhi's LNJP Hospital Begins Free Antibody Cocktail Therapy For Covid Patients
The Monoclonal Antibody Cocktail used to treat mild to moderate "high risk" Covid patients is now available at Delhi's Lok Nayak Jai Prakash Narayan Hospital (LNJP) for free.
